Endocyte Inc (NASDAQ:ECYT)

6.20
Delayed Data
As of May 22
 -0.06 / -0.96%
Today’s Change
5.01
Today|||52-Week Range
9.35
-1.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-40.5M-17.3M-18.0M5.5M
 
 
 
 
 
Depreciation262.5K358.4K674.7K857.1K
 
 
 
 
 
Total Other Cash Flow3.0M5.1M7.3M9.6M
 
 
 
 
 
Funds From Operations-37.3M-11.9M-10.1M16.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.7M-101.1M41.0M58.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-34.6M89.2M-51.1M-42.2M
 
 
 
 
 
 
InvestingIncrease In Investments-236.9M-265.2M-125.0M-149.4M
 
 
 
 
 
Decrease In Investments169.9M163.7M195.1M82.3M
 
 
 
 
 
Capital Expenditures-235.0K-1.9M-827.8K-1.5M
 
 
 
 
 
Fixed Asset Disposal0.00----10.0K
 
 
Net Cash Flow Investing-67.3M-103.4M69.3M-68.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings3.6M0.000.000.00
 
 
Long Term Debt Reduction-2.7M-13.5M0.000.00
 
 
 
Net Proceeds Stock Sale145.5M0.00644.9K103.5M
 
 
 
 
Common Preferred Redeemed0.000.000.00-3.8K
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00391.4K0.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing146.4M-13.2M644.9K103.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-5.7K707.00-6.8K-38.8K
 
 
 
 
 
 
Net Change In Cash44.5M-27.4M18.9M-7.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account